Risk Factors Associated With Progression to Intestinal Complications of Crohn's Disease in a Population-Based Cohort
Kelvin T. Thia(Singapore General Hospital), Edward V. Loftus(Mayo Clinic)
Cited by 781
Related Papers
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
|The American Journal of Gastroenterology|2015|1.8k
Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a united states community
|Gastroenterology|2003|452
Risk of Lymphoma in Patients With Inflammatory Bowel Disease Treated With Azathioprine and 6-Mercaptopurine: A Meta-analysis
|Clinical Gastroenterology and Hepatology|2014|405